<DOC>
	<DOCNO>NCT03052088</DOCNO>
	<brief_summary>This prospective clinical validation study novel regulatory approve ( CE-IVD ) diagnostic assay call ImmunoXpert™ enroll 1222 pediatric patient . The study aim externally validate tool 's diagnostic accuracy estimate potential improvement health economic outcome follow usage ImmunoXpert™ . Additionally , statistical analysis perform compare ImmunoXpert™ accuracy current practice lab test ( e.g . WBC , CRP , PCT ) clinical suspicion time requisition . Enrolled patient manage accord current standard care per standard institutional procedure .</brief_summary>
	<brief_title>Diagnostic Accuracy Diagnostic Tool Distinguishing Between Bacterial Viral Etiologies Pediatric Patients</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>Legal guardian sign inform consent Documented peak temperature ≥ 38°C ( 100.4°F ) Symptom duration ≤ 7 day Clinical suspicion RTI ( OR ) fever without clear source clinical examination Another infection episode last 3 week sample Congenital immune deficiency ( CID ) A proven suspect HIV , HBV , HCV infection Active hematological malignancy Current treatment immunesuppressive immunemodulating Other illness affect life expectancy and/or quality life</criteria>
	<gender>All</gender>
	<minimum_age>3 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>